In recent years, with the continuous improvement of the economic level, the general public has increasingly attached importance to medical and health care, and China’s medical and health industry has entered a period of rapid development. In the “Thirteenth Five-Year Plan”, healthy China has been upgraded to a “national strategy” and is expected to become an important source of new economic growth. The country’s medical consumption needs will further expand, and the health industry’s consumer market will show a huge amount. Potential and development vitality. 

This has also attracted a large amount of social capital into the medical and health industry, in order to participate in it, and achieve a win-win result for both economic and social benefits.

Zhejiang Silicon Paradise Asset Management Group（“TTGG”） has been deeply involved in many segments of the medical and health industry and has extensive theoretical knowledge and practical experience. In the near future, the Silicon Paradise Institute of Finance will join hands with related investment teams to publish an in-depth report on “2018 China's Healthcare Industry Research and Investment Advice”. This report provides an in-depth analysis of the overall development of the medical and health industry, including domestic and international development, driving factors, industrial chain, investment, and financing, as well as in vitro diagnostics, medical imaging, and specialty related to diagnosis, treatment, and rehabilitation. A number of subdivided areas such as hospitals, doctors' groups, and the pension industry and their typical enterprises have conducted research and explored the future development trends and potential investment opportunities of the medical and health industry.

Starting from mid-June, we will select some of the highlights of the report. We will publish series of articles through the "Silicon Paradise" and the "Silicon Paradise Institute of Finance" Wechat account。